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Abstract
Cholinesterase (ChE) function in schistosomes is essential for orchestration of parasite neu-
rotransmission but has been poorly defined with respect to the molecules responsible. Inter-
rogation of the S. mansoni genome has revealed the presence of three ChE domain-
containing genes (Smche)s, which we have shown to encode two functional acetylcholines-
terases (AChE)s (Smache1 –smp_154600 and Smache2 –smp_136690) and a butyrylcholi-
nesterase (BChE) (Smbche1 –smp_125350). Antibodies to recombinant forms of each
SmChE localized the proteins to the tegument of adults and schistosomula and develop-
mental expression profiling differed among the three molecules, suggestive of functions
extending beyond traditional cholinergic signaling. For the first time in schistosomes, we
identified ChE enzymatic activity in fluke excretory/secretory (ES) products and, using
proteomic approaches, attributed this activity to the presence of SmAChE1 and SmBChE1.
Parasite survival in vitro and in vivo was significantly impaired by silencing of each smche,
either individually or in combination, attesting to the essential roles of these molecules.
Lastly, in the first characterization study of a BChE from helminths, evidence is provided
that SmBChE1 may act as a bio-scavenger of AChE inhibitors as the addition of recombi-
nant SmBChE1 to parasite cultures mitigated the effect of the anti-schistosome AChE inhibi-
tor 2,2- dichlorovinyl dimethyl phosphate—dichlorvos (DDVP), whereas smbche1-silenced
parasites displayed increased sensitivity to DDVP.
Author summary
Cholinesterases—aceytlcholinesterases (AChE)s and butyrylcholinesterases (BChE)s—are
multi-functional enzymes that play a pivotal role in the nervous system of parasites by reg-
ulating neurotransmission through acetylcholine hydrolysis. Herein, we provide a detailed
characterization of schistosome cholinesterases using molecular, enzymatic and gene-
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silencing approaches and show evidence for these molecules having roles in addition to
their neuronal function. Further, we demonstrate the importance of these proteins to par-
asite development and survival through gene knockdown experiments in laboratory ani-
mals, providing evidence for the use of these proteins in the development of novel
intervention strategies against schistosomiasis.
Introduction
The functioning of the nervous system is a tightly regulated process controlled through multi-
ple catalytic and non-catalytic signaling proteins. Among the catalytic molecules, cholinester-
ases (ChEs) play a pivotal role in regulating the signaling activity of the nervous system. There
are two major types of ChEs, acetylcholinesterase (AChE) and pseudocholinesterase, or butyr-
ylcholinesterase (BChE), and they can be distinguished both kinetically and pharmacologically
[1]. AChE selectively hydrolyzes the neurotransmitter acetylcholine (ACh) to maintain neuro-
transmitter homeostasis [2] while the main role of BChE is widely accepted to be the detoxifi-
cation of organophosphorus esters which are inhibitors of AChE [3]. ChEs are generally
believed to be functionally redundant in cholinergic signaling with the main differences
between paralogs lying in their spatial and temporal expression as well as non-cholinergic
functionality [4, 5].
The nervous system of helminths has long been a potential target for therapeutic agents as
it plays several crucial roles in parasite biology that are fundamental to survival, including
coordinating motility within and outside of the host, feeding and reproduction [6–10]. The
Schistosoma nervous system is particularly important in this respect as this parasite lacks a
body cavity and circulating body fluid [11, 12] and, as a result, its signaling functions are
chiefly achieved via neurotransmission. The primary neurotransmitter that schistosomes uti-
lize is acetylcholine (ACh), which allows muscle contraction. The physiological concentration
of ACh, however, must be maintained otherwise it triggers paralysis and this is achieved pri-
marily through the action of AChE [6–8].
While AChE activity has been documented extensively in S. mansoni (reviewed in [13]),
most of the work has involved studies on parasite extracts or native SmChE purified by inhibi-
tor- affinity chromatography, making it difficult to attribute function to any one particular
SmChE molecule. More recent studies have documented two AChE-encoding genes in S. man-
soni and other species [14–16]. In 2016, You et al. characterized AChE activity in S. japonicum
extracts and at a molecular level, but only through the expression of one recombinant AChE
[17]. Moreover, to the best of our knowledge, genes encoding proteins with BChE activity have
not been previously described in schistosomes or any other helminth. Interrogation of the
now fully annotated S. mansoni genome [18] has revealed three different SmChE paralogs;
however, their individual contributions to ChE function remain unknown.
Traditionally, ChEs have been regarded solely as neurotransmitter terminators; however,
there is increasing data to suggest that these enzymes play a variety of roles that extend beyond
this cholinergic function due to their presence in multiple cell types and subcellular locations
[4, 5, 19, 20]. In schistosomes, AChE has been localized to the tegument as well as the neuro-
musculature [17, 21, 22] and a proposed function for tegumental AChE has been mediation of
glucose uptake by the parasite from the external environment [23]. The exact mechanism for
this process is still unclear but the proposed initiating step is by limiting the interaction of host
ACh with tegumental nicotinic ACh receptors (nAChRs), a hypothesis bolstered by the obser-
vation that glucose uptake is ablated by the use of membrane-impermeable AChE and nAChR
Cholinesterase paralogs of Schistosoma mansoni
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inhibitors in S. mansoni [23, 24] and RNAi-mediated AChE silencing in S. japonicum [25].
The nAChRs are also associated both spatially and temporally with surface AChE expression
and are concentrated on the tegument [26], the major site of glucose uptake [27].
Many intestinal nematodes secrete AChE [28–31], which, where studied, orchestrate exoge-
nous cholinergic activities. It has also been indirectly shown that the nematode N. brasiliensis
employs parasite-derived AChE to alter the host cytokine environment to inhibit M2 macro-
phage recruitment, a condition favorable to worm survival [32]. Despite this breadth of litera-
ture in nematodes, there has been no documentation of secreted AChE activity from
schistosomes.
Herein we describe and functionally characterize using gene silencing and enzymatic
approaches, a novel AChE and BChE from S. mansoni and further characterize the only previ-
ously identified AChE-encoding gene from the parasite. Importantly, we show through gene
knockdown that each smche is essential to S. mansoni development and survival, highlighting
them as targets for novel anti-schistosomal intervention strategies.
Results
Identification of novel genes encoding ChE proteins in S. mansoni
Three putative ChE paralogs were identified from interrogation of the S. mansoni genome:
smache1 (Smp_154600), smbche1 (Smp_125350) and smache2 (Smp_136690). The predicted
SmChEs were then aligned with characterized AChE enzymes from Homo sapiens, the electric
eel Torpedo californica, and the nematode Caenorhabditis elegans (Fig 1). Homology analysis
of amino acid sequences revealed that SmAChE1, SmBChE1, and SmAChE2 share (32–35%)
sequence identity and (49–52%) sequence similarity. Further, all SmChEs have 36–40% amino
acid identity with H. sapiens and T. californica AChE. All identified SmChEs had ChE-specific
characteristics, including a catalytic triad with an active site serine, which is required for ester
hydrolysis [33]. Interestingly, the His residue of the catalytic triad of SmBChE1 appears to
have been substituted for Gln, a change consistent among all the BChE1 homologs shown for
other Platyhelminthes, but not nematode or model organism BChE1 sequences (S1 Fig). A 3D
model of the three SmChEs was constructed by homology modeling with AChE from model
organisms (H. sapiens and T. californica (S2 Fig). All three SmChEs exhibited predicted folding
characteristics of the functional globular enzymes as most of the α-helical and β-stranded
sheets were tightly aligned. Each predicted SmChE structure consisted of a ChE catalytic
domain but, although the core architecture of the catalytic gorges was well aligned, regions
that are associated with substrate specificity and catalytic efficiency were disparate. In particu-
lar, and in agreement with the sequence alignment, the catalytic triad of SmBChE1 was pre-
dicted to be Ser-Gln-Glu instead of the canonical Ser-His-Glu present in the other two
paralogs. A phylogenetic tree of the alignment (S3 Fig) shows that SmChEs were clustered into
three distinct branches, with SmChE1 being phylogenetically distinct from SmBChE1 and
SmAChE2. In addition, each SmChE was grouped together with closely related flatworms,
including other Schistosoma species. Importantly, as shown in the sequence alignment,
SmChEs are divergent from the human homolog. Reflective of the catalytic triad residue differ-
ence (S1 Fig), trematode BChEs are phylogenetically divergent from nematode and human
BChEs (S4 Fig).
Developmental expression analysis of SmChE genes
Gene expression patterns of the three SmChE paralogs across different developmental stages
were measured using semi-quantitative qPCR (Fig 2A–2C) and this data was used to generate
a comparative expression heat map of all three genes (Fig 2D). While all smche developmental
Cholinesterase paralogs of Schistosoma mansoni
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expression patterns were variable, the transcript levels of all three genes were relatively lower
Fig 1. The amino acid sequence alignment and phylogeny of ChEs from S. mansoni and other species. Light blue
arrowheads = the 14 aromatic rings, black arrowheads = oxyanion holes, S = salt bridges, red boxes = PAS, yellow
boxes = catalytic triad, green boxes = acyl binding pocket, numbered arrows = disulfide bonds and magenta box = peripheral
anionic site. Accession numbers: H. sapiens (NP000656), T. californica (CAA27169), C. elegans (NP510660), SmAChE1
(Smp_154600), SmBChE1 (Smp_125350), SmAChE2 (Smp_136690).
https://doi.org/10.1371/journal.ppat.1008213.g001
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in cercariae compared to the other developmental stages. Overall, the transcript levels of
smache1 and smache2 genes in most life stages were higher than that of smbche1. In adult
worms, smache1 was expressed at higher levels, specifically in male parasites, followed by
sporocysts.
Immunolocalization of SmChEs
To gain insight into the anatomical sites of expression of ChE proteins in S. mansoni, SmChEs
were immunolocalized in whole juvenile and sectioned adult parasites. In adults, and
Fig 2. Developmental expression profiles of smache1, smbche1 and smache2. The expression of (A) smache1, (B) smbche1and (C) smache2 genes at
different developmental stages of S. mansoni as quantified by qPCR analysis. (D) The heat map shows the comparative expression pattern of the paralogs in
each developmental stage. Data are presented as mean ± SEM of five independent experiments and are normalized to the smcox1 housekeeping gene.
https://doi.org/10.1371/journal.ppat.1008213.g002
Cholinesterase paralogs of Schistosoma mansoni
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consistent with their predicted cholinergic function, all SmChEs were expressed throughout
the worms’ internal structures (presumably localizing to the neuromusculature) and on the
tegument surface. SmAChE1 was the least uniformly distributed of all SmChEs, localizing
mostly to the tegument (Fig 3A). Additionally, anti-SmChE antibodies were able to detect
homologous ChEs in adult S. haematobium sections. SmChE proteins were detected in all
stages of larval development tested and, as was the case with adult worms, localized to the tegu-
ment (Fig 3B).
Expression and ChE activity of SmChEs
Soluble, functionally active proteins were expressed in P. pastoris, purified via IMAC and
tested for ChE activity. Both SmAChE1 and SmAChE2 demonstrated significantly stronger
hydrolase activity when AcSCh was used as a substrate, compared to SmBChE1 and, con-
versely, SmBChE1 hydrolyzed BcSCh to significantly higher levels compared to SmAChE1 and
SmAChE2 (Fig 4A). All paralogs exhibited Michaelis–Menten kinetics (Table 1) when hydro-
lyzing their designated substrate, with SmAChE1 having a substrate affinity approximately
twice that of SmAChE2. In addition, preferred substrate activity of both SmAChE1 and
SmAChE2 was inhibited by DDVP, an AChE inhibitor, whereas iso-OMPA, a specific inhibi-
tor of BChE, only inhibited SmBChE1 activity (Fig 4B).
BChE and secreted ChE activity in schistosomes
Although the presence of nonspecific ChE activity has long been known in schistosomes [34],
the identity of the gene product and its function remain unknown. Prompted by the identifica-
tion of SmBChE1 as a BChE, based on its substrate preference and enzymatic inhibition by
iso-OMPA, we sought to investigate the distribution of BChE activity in juvenile and adult
schistosomes. Extracts from S. mansoni schistosomula had higher BChE activity compared to
S. mansoni adult worms (Fig 5A), and that activity was significantly greater in S. mansoni com-
pared with S. haematobium adults (Fig 5B). Varied amounts of AChE activity were detected in
ES from all developmental stages tested. ES products from adult males had double the AChE
activity of adult female ES products (P< 0.001), while cercariae ES exhibited the highest activ-
ity (at least ten-fold more than male ES products (P< 0.0001)) and egg ES had the lowest (Fig
5C). Availability of ES precluded the measurement of secreted BChE activity from all develop-
mental stages but, of those tested, activity in schistosomula ES products was the highest—twice
as high as that of adult (P< 0.01) and cercariae (P< 0.01) ES (Fig 5D). SmChEs were purified
from ES products of S. mansoni adult worms using edrophonium–sepharose affinity chroma-
tography. Purification resulted in an activity increase of more than 200-fold relative to crude
ES (Fig 5E). Resolution of the purified proteins by SDS-PAGE resulted in a doublet with a
major band migrating at 70 kDa under denaturing and reducing conditions (Fig 5F). The
identity of purified, secreted SmChEs was substantiated by in-gel LC-MS/MS analysis with the
peptide data generated used to interrogate the S. mansoni proteome (predicted from the S.
mansoni genome - http://www.genedb.org/Homepage/Smansoni)). The false discovery rate
was set at<1% and only proteins with at least two unique peptides having significant Mascot
identification scores (P< 0.05) were considered. The top protein hits were identified as
SmAChE1 (Smp_154600) and SmBChE1 (Smp_125350); SmAChE1 had a relative abundance
of more than 40-fold that of SmBChE1 (S3 Table).
RNAi-mediated smche transcript and SmChE protein reduction
Schistosomula electroporated with smache1 siRNA showed respective decreases in SmAChE1
mRNA levels of 43% (P� 0.05) and 84% (P� 0.001) at three and seven days post-treatment,
Cholinesterase paralogs of Schistosoma mansoni
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respectively, compared to the luc control (Fig 6A), while treating parasites with smbche1
siRNA caused 51.0% (P� 0.001) and 78% (P� 0.001) suppression of smbche1 mRNA expres-
sion at day 3 and 7 after electroporation, respectively, compared to the luc control (Fig 6B).
Treatment of schistosomula with smache2 siRNA resulted in respective decreases in smache2
Fig 3. Immunofluorescent localization of SmChEs. Fluorescence and brightfield images of (A) male (M) and female
(F) S. mansoni and S. haematobium adult worm sections. (B) Fixed cercariae, and schistosomula at 3 h, 24 h, 3 days
and 5 days after transformation. Both adult sections and juvenile parasites were labeled with either anti-SmAChE1,
anti-SmBChE1 or anti-SmAChE2 primary antibody (1:100 in PBST) followed by goat-anti-mouse IgG-alexafluor 647
(1:200 in PBST). Naive mouse serum was used as a negative control.
https://doi.org/10.1371/journal.ppat.1008213.g003
Fig 4. Enzymatic activity of SmChEs. (A) Cholinergic substrate preference (AcSCh or BcSCh) of each SmChE. (B) Inhibition of SmAChE1 (10 μg) and SmAChE2
(10 μg) with 1 μM DDVP (AcSCh used as a substrate) and inhibition of SmBChE1 (10 μg) with 1 mM iso-OMPA (BcSCh used as a substrate). Data are presented as
mean ± SEM of triplicate experiments and differences between groups were measured by the student’s t test. �P� 0.05, ��P� 0.01, ���P� 0.001.
https://doi.org/10.1371/journal.ppat.1008213.g004
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mRNA levels of 60% (P� 0.001) and 47% (P� 0.01) five and seven days after electroporation,
compared to the luc control (Fig 6C). Schistosomula electroporated with a cocktail of all three
smche siRNAs showed decreases of all three transcript levels over time, with smache2 mRNA
levels decreasing by an average of 90% (P� 0.001) by day 3 after treatment, compared to the
luc control (Fig 6D).
Seven days after treatment with smache1, smbche1 or smache2 siRNAs, schistosomula
showed decreases in SmAChE1, SmBChE1 or SmAChE2 protein expression of 73%, 59% and
46%, respectively, compared to luciferase controls (Fig 6E).
Suppression of SmChE activity
Suppression of AChE activity was seen in smache1 and smache2 siRNA-treated parasites from
5 and 3 days after electroporation, respectively (Fig 7A), compared to the luc control, while
schistosomula treated with smbche1 siRNA did not show any significant reduction in BChE
activity, even 7 days after electroporation (Fig 7B). Parasites electroporated with a cocktail of
all three smche siRNAs showed significant decreases in AChE activity at 3 days (62% reduction,
P� 0.001), 5 days (67% reduction, P� 0.001) and 7 days (71% reduction, P� 0.001) after
treatment (Fig 7C). BChE activity was not measured in the cocktail siRNA treatment group.
Individual silencing of smache1 or smache2 genes and combined silencing of all three
smche genes reduced glucose uptake in schistosomula by 24.9% (P� 0.001), 32.34%
(P� 0.001) and 38.61% (P� 0.001) at 48 h post-treatment, respectively, relative to the luc con-
trol. However, smbche1-silenced parasites showed no significant changes in glucose uptake at
the same timepoint and there was no difference in the glucose consumed by the smache1 or
smache2 siRNA-treated groups compared with the cocktail siRNA-treated group (Fig 7D).
Transcript levels of the glucose transporters, sgtp1 and sgtp4, were neither decreased nor signif-
icantly increased in individual or cocktail smche-silenced parasites (S5 Fig).
Effects of smche silencing on schistosomula viability in vitro and
development in vivo
Parasites treated with smache1, smbche1 or smache2 siRNAs showed significant decreases in
viability at days 3, 5 and 1 after treatment, respectively, compared to luc controls. At days 5
and 7 post-treatment, the most significant decrease in parasite viability was seen in the group
which received the cocktail siRNA treatment, compared to luc controls. Furthermore, viability
in this group was also significantly lower than it was for any individual treatment at these two
time points (Fig 8A).
To examine whether RNAi-mediated smche suppression reduced parasite viability in vivo,
mice were infected with smche-silenced parasites and worm burdens were measured after
three weeks. From two independent experiments, there was an average 88.15%, 55.15%,
Table 1. Kinetic parameters of SmChEs.
SmChE paralog Vmax (nmol/min/mg) Km (mM)
SmAChE1 5.57 ± 0.54� 5.83 ± 1.62�
SmAChE2 5.59 ± 1.37� 10.87 ± 6.17�
SmBChE1 1.7 ± 0.09# 34.38 ± 12.71#
�Hydrolysis of AcSCh.
#Hydrolysis of BcSCh.
https://doi.org/10.1371/journal.ppat.1008213.t001
Cholinesterase paralogs of Schistosoma mansoni
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75.95% and 88.35% decrease in adult fluke burdens from mice injected with smache1-,
smbche1-, smache2- and smche cocktail-silenced schistosomula, respectively, compared to
mice infected with luc-treated parasites (Fig 8B and 8C). All worm burden decreases were sig-
nificant and there was no significant difference in fluke burdens between mice injected with
luc-treated parasites and non-electroporated control parasites. All mice had been successfully
infected with parasites, as serum from necropsied mice contained parasite-specific antibodies
(S6A Fig). No reduction in smche transcript levels were observed in smche-silenced parasites
recovered from necropsied mice (S6B Fig).
Bio-scavenging of carboxylic esters by SmBChE1
The hypothesis that SmBChE may act as a molecular decoy in schistosomes to detoxify the
effects of organophosphorus AChE inhibitors was examined by testing whether, firstly,
Fig 5. BChE and secreted ChE activity in schistosomes. (A) BChE activity in S. mansoni adults and schistosomula TX-100 extracts. (B) BChE activity in TX-100
extracts (20 μg) from S. mansoni and S. haematobium. (C) AcSCh conversion activity and (D) BChE activity in ES products (20 μg) from different developmental stages
of S. mansoni. (E) AsCSh conversion activity and (F) SDS-PAGE analysis of purified, secreted SmChEs. Data are presented as mean ± SEM of triplicate experiments and
differences between groups were measured by the student’s t test. �P� 0.05, ��P� 0.01.
https://doi.org/10.1371/journal.ppat.1008213.g005
Cholinesterase paralogs of Schistosoma mansoni
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addition of DDVP (an organophosphorous AChE inhibitor) to parasite extracts or recombi-
nant SmBChE1 inhibited BChE activity, secondly, inhibition of parasite-derived BChE poten-
tiated the effects of DDVP and, thirdly, addition of exogenous BChE (SmBChE1) mitigated the
effects of DDVP. Firstly, BChE activity of schistosome extracts and recombinant SmBChE1
significantly decreased in the presence of increasing concentrations of DDVP (Fig 9A and 9B,
respectively). Secondly, DDVP-mediated killing of schistosomula was significantly increased
Fig 6. Suppression of smche mRNA transcript and protein expression in schistosomula by RNAi. Individual siRNA treatment with (A) smache1, (B) smbche1 or (C)
smache2 siRNAs. (D) Treatment with a cocktail of smache1, smbche1 and smache2 siRNAs. Transcript levels of each smche in parasites treated with smche siRNAs are
shown relative to smche transcript expression in schistosomula treated with the luc control siRNA (dashed line) and represent the mean ± SEM of triplicate qPCR assays
from 2 biological replicates of each treatment. Transcript expression in all parasites was normalized with the housekeeping gene, smcox1. Differences in transcript levels
(relative to the luc control) were measured by the student’s t test. �P� 0.05, ��P� 0.01, ���P� 0.001. (E) Western blot of day 7 schistosomula extracts following
treatment with smche or luc siRNAs. Extracts were immunoblotted with the corresponding anti-SmAChE1, anti-SmBChE or anti-SmAChE2 polyclonal antibody. An
antibody against SmPmy (paramyosin) was used as a loading control.
https://doi.org/10.1371/journal.ppat.1008213.g006
Cholinesterase paralogs of Schistosoma mansoni
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in the presence of iso-OMPA (60.9% compared with 21.8%; P< 0.0001) (Fig 9C). AChE activ-
ity in live parasites was not affected by the addition of iso-OMPA (S7A and S7B Fig). Further,
smbche1-silenced schistosomula were significantly more susceptible to DDVP-mediated kill-
ing than luc-treated controls (67.8% compared with 27.5%; P< 0.0001) (Fig 9D). The iso-
OMPA addition experiment was attempted using extracts and, while AChE activity in DDVP-
treated schistosome extracts significantly decreased in the presence of increasing amounts of
the BChE inhibitor, iso-OMPA, it also decreased, albeit to a lesser degree, when iso-OMPA
was added to extracts without DDVP (S8A Fig). Thirdly, schistosomula were increasingly
resistant to DDVP-mediated killing with the addition of increasing amounts of recombinant
protein to the culture media (Fig 9E). The SmBChE1 addition experiment was attempted
using extracts and, while AChE activity in DDVP-treated extracts was significantly increased
Fig 7. Effects of smche knockdown on cholinesterase activity and glucose uptake. (A) AcSCh conversion activity of extracts (20 μg) from schistosomula
treated with smache1, smache2 or luc siRNAs (dashed line). (B) BChE activity of extracts (20 μg) from schistosomula treated with smbche1 or luc siRNAs (dashed
line). (C) AChE activity of extracts (20 μg) from schistosomula treated with all 3 siRNAs or luc siRNA (dashed line). (D) Glucose uptake by schistosomula 48 h
after treatment with smche siRNAs. Schistosomula (5 days old– 5,000/treatment) were electroporated with either luc or smche siRNAs and glucose consumption
was measured 48 h after treatment. Data represents mean ± SEM of duplicate assays from 2 biological replicates of each treatment. Differences (relative to the luc
control) were measured by the student’s t test. ��P� 0.01, ���P� 0.001.
https://doi.org/10.1371/journal.ppat.1008213.g007
Cholinesterase paralogs of Schistosoma mansoni
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in the presence of SmBChE, it also increased when SmBChE was added to extracts without
DDVP, albeit to a lesser degree (S8B Fig).
Discussion
Cholinesterase (ChE) activity in S. mansoni was first described by Bueding in 1952 [34] and
was well characterized biochemically in the four decades succeeding this discovery. The tech-
nological limitations of this time period meant that most of the evidence for SmChEs came
from whole worm studies and analyses of crude parasite extracts (reviewed in [13]), which
could not ascribe ChE activity to any particular protein. Several studies in the early 2000’s
characterized a single AChE from S. mansoni (Smp_154600 in the current gene annotation
nomenclature) and its direct homolog in other species of schistosomes [14, 15, 22], but lack of
Fig 8. Effects of smche silencing on schistosomula viability in vitro and development in vivo. (A) Schistosomula treated with individual or a cocktail of all 3
smche siRNAs or luc siRNA were cultured for 7 days in complete Basch medium with viability determined at day 1, 3, 5 and 7 after treatment by Trypan Blue
exclusion (mean ± SEM of duplicate assays from 2 biological replicates of each treatment). (B and C) One-day-old schistosomula treated with individual or a
cocktail of all three smche siRNAs or luc siRNA were intramuscularly injected (2,000 parasites) into mice. After 3 weeks, adult worms were recovered and
counted. Data from two independent experiments are shown. Differences between smche- and luc-treated groups were measured by the student’s t test.
�P� 0.05, ��P� 0.01, ���P� 0.001.
https://doi.org/10.1371/journal.ppat.1008213.g008
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a comprehensive schistosome genome annotation at the time precluded identification of more
ChE family members. Interrogation of the most recent iteration of the S. mansoni genome
assembly has identified two additional ChE-encoding genes that are paralogs to Smp_154600
(which we have termed SmAChE1); Smp_125350 (SmBChE1) and Smp_136690 (SmAChE2).
In this current study, we have provided a more in-depth characterization of the previously
documented SmAChE1 and two additional ChEs from S. mansoni: SmAChE2 –an AChE
which has recently been characterized in terms of its gene expression in adult S. mansoni [16];
and SmBChE1 –a BChE which, to the best of our knowledge, has never been documented in
the helminth literature.
Fig 9. SmBChE1 bio-scavenges DDVP and protects parasites against DDVP-induced effects. (A) Schistosomula extracts were treated with DDVP (1, 2 and 5 μM)
and then assayed for BChE activity. (B) Recombinant SmBChE1 (10 μg) was treated with DDVP (1, 5 and 10 μM) and then assayed for BChE activity. (C) Schistosomula
were treated with DDVP (1 μM) or pretreated with iso-OMPA (100 μM) and then DDVP, and parasite viability was measured 5 h after treatment. Identical experiments
were performed in the absence of DDVP to control for any loss of parasite viability due to iso-OMPA alone. (D) smbche1-silenced or luc siRNA-treated schistosomula
were treated with DDVP (1 μM) and parasite viability was measured 5 h after treatment. Identical treatments in the absence of DDVP were used as controls. (E) DDVP
was pre-incubated with SmBChE1 (10, 5 and 2.5 μg) or 10 μg of SmTSP2 for 1 h before being used to treat schistosomula. Parasite viability was measured 24 h post-
treatment. For all assays involving schistosomula, data are the average ± SEM of duplicate biological and triplicate technical experiments and for all other assays, data is
the average ± SEM of triplicate experiments. Differences were measured by the student’s t test. �P� 0.05, ���P� 0.001, ����P� 0.0001.
https://doi.org/10.1371/journal.ppat.1008213.g009
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All SmChEs share a modest level of identity which is consistent with their divergence over
evolutionary time, an occurrence that is possibly due to a series of gene duplications due to the
phylogenetic distance between the relative clades. This divergence between SmChEs and, also,
ChEs of other organisms, provides evidence for the increasing reports of non-cholinergic func-
tions of ChEs in the literature. Additionally, the relative lack of sequence identity between
SmChEs and human ChEs suggests potential scope for the development of intervention strate-
gies targeting schistosome ChEs that will not affect the host. Despite the diversity between
ChEs, all enzymes analyzed herein would appear to be enzymatically active as they possessed a
catalytic triad with an active site serine, the amino acid responsible for ester hydrolysis [33]. It
is interesting to note, however, the catalytic triad His–Gln substitution in SmBChE1 (and the
other platyhelminth BChE1 homologs); while this change is not a hallmark of model BChEs,
that it occurs within an entire parasite lineage is noteworthy and will be investigated further.
The transcript levels of each smche varied among parasite developmental stages and this is
likely a response to the differing cholinergic and cholinesterase-independent requirements of
the parasite throughout its lifecycle. For example smache1 is expressed at a higher level in adult
males than females, probably due to the more “muscular” roles of attachment and movement
orchestrated by the male compared to the female, which remains sedentary once inside the
gynecophoric canal of the male [35]. This hypothesis is supported by the additional observa-
tion that smache1 is downregulated in females after pairing [16]. Expression of smbche1 was
highest in the egg stage; there is evidence for BChE involvement in chicken embryo neurogen-
esis and development, independent of its enzymatic function [36], which suggests that
SmBChE1 could play a role in parasite embryogenesis. The miracidium and sporocyst stages
had the highest levels of smache2 expression, in agreement with Parker-Manuel et al [37].
Immunolocalization of the SmChEs revealed apparent expression in the neuromusculature
and tegument to varying degrees, depending on the paralog, and is consistent with early locali-
zation experiments [21], although the antibodies used in those studies were raised against
AChEs purified from parasite extracts and so the localization could not be attributed to a spe-
cific family member. Tegumental distribution is suggestive of non-neuronal cholinergic and/
or non-cholinergic roles. Indeed, surface-expressed SmAChE has been implicated in mediat-
ing glucose scavenging by the parasite, as this process can be ablated by membrane-imperme-
able AChE inhibitors [23, 24]. Tegumental SmAChE may also act to hydrolyze exogenous
ACh, neutralizing its immune-mediating function to create an environment more conducive
to parasite establishment [32]. The localization of these proteins to the tegument of schistoso-
mula should also be noted since early developing schistosomula are considered most vulnera-
ble to immune attack [38], and so SmAChE-targeted immunotherapeutics could be used
effectively to vaccinate against schistosomiasis. Indeed, antibodies against SmAChEs have
been shown to interact with the surface of schistosomula, resulting in complement-dependent
killing of the parasite [39].
Full-length and functional SmChEs were expressed in P. pastoris. SmAChE1 had preferred
substrate specificity for AcSCh over BcSCh, albeit at a three-fold lower affinity than previously
reported for SmAChE1 expressed in Xenopus laevis oocytes [15]. SmAChE2 also had a sub-
strate preference for AcSCh and an affinity twice that of SmAChE1. Extremely low enzyme
activity was observed with SmBChE1 when AcSCh was used as a substrate, but enzymatic
activity significantly increased with the use of BcSCh as the substrate. Although sequence
alignment of SmBChE1 with the other two SmChEs revealed a single amino acid substitution
in the peripheral anionic site (Glu–Trp), acyl binding pocket (Val–Leu) and catalytic triad
(His–Gln), it was unclear whether these changes alone were enough to classify SmBChE1 as a
BChE; based on the significant difference in substrate preference, however, this classification
would appear valid. Cloning of a recombinant BChE from S. mansoni is consistent with our
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observations of BChE activity in parasite extracts, and S. mansoni schistosomula exhibited sig-
nificantly more activity than adults, as did S. mansoni compared to S. haematobium adults. It
has been reported that S. mansoni is more sensitive to the BChE inhibitor, iso-OMPA, than S.
haematobium [40] and it may be due to the increased BChE activity in S. mansoni. Indeed, this
relationship has been documented between AChE and metrifonate (precursor of DDVP used
in this study); S. haematobium is more sensitive to the inhibitor than S. mansoni because of the
greater amount of AChE on the worm’s surface [40].
For the first time, we document the presence of secreted SmChE activity in schistosomes
and AChE activity was highest in cercarial ES products. Of the intra-mammalian stages tested,
AChE activity was highest in schistosomula and adults and may be acting to bind and neutral-
ize exogenous AChE inhibitors (thus protecting tegumental and somatic AChE) or host-
derived ACh to mitigate the immunomodulatory effects of this molecule. Extending this
hypothesis, ES products from cultured female worms had lower AChE activity than males and
could be due to females having less of a requirement for this defensive mechanism as they
reside in the relative shelter of the gynecophoric canal. BChE activity was present in the ES
products of adults, schistosomula and cercariae and was significantly higher in the intra-mam-
malian larval stage than the other two stages. The SmChE molecules present in ES were iso-
lated by purification on edrophonium (a reversible ChE inhibitor) sepharose and, consistent
with the class of activity observed in ES, identified by mass spectrometry as SmAChE1 and
SmBChE1; the former being forty-fold more abundant than the latter.
RNAi-mediated silencing of smache1 and smache2 in schistosomula showed decreases in
AChE activity, consistent with reductions in transcript and protein expression levels. More-
over, inhibition of this biochemical activity was greater in schistosomula treated with the
smche siRNA cocktail than parasites receiving any of the individual treatments, further evi-
dence suggestive of simultaneous silencing of all smache paralogs. AChE activity inhibition in
smache2-silenced parasites was more pronounced than in smache1-silenced parasites, which
was inconsistent with protein level reductions and this may be due to the increased AChE
activity reported for SmAChE1 (Vmax = 5.57 nmol/min/mg, Km = 5.83 mM) compared to
SmAChE2 (Vmax = 5.59 nmol/min/mg, Km = 10.87 mM).
Previous studies have documented the involvement of SmChEs in the uptake of exogenous
glucose by schistosomes through the ablation of the glucose uptake pathway by organophos-
phorus [40] and large molecule [24] AChE inhibitors, so we sought to identify the SmChE
paralog(s) responsible for this mediation through the use of RNAi targeting smche genes. Indi-
vidual gene knockdown of smache1 and smache2 suppressed glucose uptake in schistosomula,
implying that both genes were involved in regulation of this mechanism. Glucose uptake in
these experiments was normalized to the amount of viable parasites in each treatment to con-
trol for any observed loss of uptake due to parasite death. Tegumental AChE is speculated to
mediate glucose uptake by limiting the interaction of ACh with tegumental nicotinic ACh
receptors which is thought to decrease the amount of glucose uptake through surface glucose
transporters. The fact that both molecules are localized to the tegument and can hydrolyze
ACh therefore provides evidence for their role in this pathway. Silencing of smbche1 in schisto-
somula did not show any difference in glucose uptake and is probably reflective of the mole-
cule’s limited role in ACh hydrolysis. Transcript levels of sgtp1 and sgtp4 were not significantly
changed in smache1- and smache2-silenced parasites, suggesting that SmAChEs may facilitate
glucose uptake in a manner which does not directly involve glucose transporters. Indeed, at
least in nematodes, AChEs have been proposed to be involved in altering the permeability of
surrounding host cells, allowing nutrients (such as glucose) to leak into the parasite niche and
be uptaken [41].
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Individual smche silencing in schistosomula resulted in significant decreases in parasite via-
bility at various timepoints after treatment, with smache2-silenced parasites showing the most
rapid and significant decrease in viability after treatment. Of the smche paralogs studied,
smche2 is the only one whose expression is significantly upregulated between S. mansoni cer-
cariae and schistosomula [37], an observation consistent with qPCR data, and so silencing this
relatively highly expressed gene may have the most profound effects of all smche silencing on
parasite viability. The viability of parasites treated with all three smche siRNAs was significantly
decreased compared to parasites treated with an individual siRNA, suggesting functional over-
lap exists between the paralogs. This redundancy has been documented in AChE-knockout
mice where BChE has the ability to hydrolyze ACh in the absence of AChE [42, 43]. Moreover,
AChE deletion is found to be lethal in Drosophila only because there is no alternative BChE
paralog to compensate for the lack of ACh hydrolysis [44, 45]. Similar to the observations in
this study, simultaneous knockdown of multiple ChE genes has been reported to have deleteri-
ous effects on their target organisms including the insects Plutella xylostella [46], Chilo sup-
pressalis [47] and Tribolium castaneum [48] and the nematodes Nippostrongylus brasiliensis
[49] and Caenorhabditis elegans [50]. Similarly, chemotherapy with “broad spectrum” ChE
inhibitors has shown to be effective against a range of organisms, including pest insects [51],
schistosomes [24, 52–54] and parasitic nematodes [55]. It is likely that the simultaneous silenc-
ing of the smche genes in this study has a profound effect on parasite viability due to the knock-
down of cholinergic signaling, a process to which all paralogs contribute, as they have all been
shown to hydrolyze ChE substrates. Also possible is that knockdown of these three genes
might have resulted in the ablation of multiple other functions that have been suggested for
these molecules [5, 48, 56]. Reflective of in vitro silencing experiments, worm recovery from
mice infected with all groups of smche-silenced parasites was significantly less than controls,
indicating that suppression of smache1, smbche1 or smache2 could inhibit schistosome estab-
lishment and/or development in the host. An immunomodulatory function that results in a
host environment favorable to parasite survival has been suggested for AChE secreted by N.
brasiliensis [32] and so it may be that, if schistosome ChEs have similar non-neuronal roles,
impairment of ChE function in these parasites may lead to more efficient immune-mediated
worm expulsion. There is now a growing body of evidence that AChEs play non-classical roles
as adhesion molecules [4, 57, 58] due to these two protein families sharing significant domain
homology and so SmChE-silenced worms may be unable to properly establish in their site of
predilection due to impaired adherence to host vasculature. Schistosomula silenced for all
three smche genes exhibited the highest mortality in vivo when worm recovery was averaged
across the two independent trials, suggesting that, not only is simultaneous knockdown of
SmChEs required to overcome any functional redundancy between the molecules, but that this
treatment has the largest impact on parasite pathogenesis due to the inhibition of multiple bio-
logical functions collectively orchestrated by these proteins.
The smche transcript levels of silenced worms recovered from mice were no different from
control parasites and it is likely that the surviving worms received less siRNA than those
worms that died in the host. Alternatively, surviving worms might have recovered from the
transient effects of RNAi, highlighting the advantage of targeted gene knockout techniques
such as CRISPR/Cas9 which has recently been reported for the first time in schistosomes [59].
It is generally accepted that vertebrate BChE has a predominant role in the detoxification of
ingested or inhaled drugs and poisons such as the AChE-inhibitory organophosphorous esters
that constitute nerve agents and pesticides due to the binding of the enzyme to these mole-
cules, resulting in blockade of their active site (reviewed in [3]). The addition of the organo-
phophorous AChE inhibitor, DDVP, to schistosome extracts decreased extract BChE activity,
suggesting a similar detoxification role exists for schistosome BChE as for the vertebrate
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enzyme. Moreover, inactivation of SmBChE1 in live schistosomula by the BChE inhibitor iso-
OMPA or through RNAi-mediated silencing potentiated the parasite-killing effects of DDVP
(presumably less BChE available for DDVP binding and inactivation) whereas addition of
exogenous SmBChE1 mitigated the results (presumably more BChE available for DDVP bind-
ing and inactivation), further supporting this hypothesis. It should be noted, however, that
when AChE activity was used as a readout for similar experiments performed on extracts, the
data was less compelling and could be due to the fact that BChE has a role (albeit limited) in
ACh hydrolysis and so modification of BChE availability could have impacted on AcSCh con-
version, confounding assay results. Numerous plant species in the Solanaceae used for their
nutritional value (potatoes, for example) and others employed in traditional medicine for their
anthelmintic properties contain naturally-occurring AChE-inhibitory compounds [60, 61],
and so it may be that the evolution of this dietary behavior in schistosomiasis endemic popula-
tions has resulted in selective pressure on the parasite to produce these particular ChE mole-
cules. The localization of SmBChE1 to the tegument and its presence in ES products may
further support this hypothesis, as the enzyme would be spatially available to interact with tox-
ins present in the host environment, thus safeguarding parasite AChE against AChE inhibi-
tors. Moreover, BChE activity is higher in S. mansoni than S. haematobium, which is more
sensitive to the effects of the organophosphorous AChE inhibitor metrifonate. It has been
reported that this sensitivity is due to the larger amount of tegumental AChE present in S. hae-
matobium [40], but it may also be due to the reduced amount of BChE available to detoxify the
inhibitor, as a similar relationship has been reported in studies which use human BChE to
counter organophosphate toxicity [62]. Plasma-derived human BChE is currently in a phase I
clinical trial as a nerve agent detoxifier, and a recombinant human BChE mutant is being used
to prevent relapse in cocaine addicts due to the enzyme’s ability to hydrolyze the drug into
inactive by-products [3]. One of the major limitations of these approaches, however, is the cat-
alytic turnover of human BChE [3] and so there is emphasis on the identification of BChE
homologues from other organisms, such as SmBChE1, that might offer improved detoxifica-
tion activity in this regard.
Inhibition of BChE in the absence of DDVP results in parasite death so a bio-scavenging
role is possibly not the only function of this enzyme. Indeed, vertebrate BChE has also been
shown to have roles in (1) ACh hydrolysis in situations of AChE deficiency [63], (2) fat metab-
olism by hydrolyzing the feeding stimulant peptide octanoyl ghrelin [64], and (3) scavenging
polyproline-rich peptides to regulate protein-protein and protein-DNA interactions [65].
In summary, the work herein has identified multiple ChE paralogs in the genome of S. man-
soni where previous studies, making use of the technology available at the time, attributed ChE
activity to a single AChE. Consistent with previous observations that ChEs are multi-faceted
enzymes, we posit that the three ChE paralogs described herein may fulfil distinct neuronal
and non-neuronal functions based on their anatomical and temporal expression in the parasite
and its ES products and the enzymatic activity of recombinant molecules. In addition to pro-
viding valuable insight into the functionality of individual ChE molecules, the study herein
documents the essentiality of these proteins, providing a compelling evidence base for their
use as intervention targets against schistosomiasis.
Materials and methods
Ethics statement
All experimental procedures reported in the study were approved by the James Cook Univer-
sity (JCU) animal ethics committee (ethics approval numbers A2271 and A2391). Mice were
maintained in cages in the university’s quarantine facility (Q2152) for the duration of the
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experiments. The study protocols were in accordance with the 2007 Australian Code of Prac-
tice for the Care and Use of Animals for Scientific Purposes and the 2001 Queensland Animal
Care and Protection Act.
Parasite maintenance, culture and ES collection
Biomphalaria glabrata snails infected with S. mansoni (NMRI strain) were obtained from the
Biomedical Research Institute (BRI), MD, USA. Cercariae were shed from infected snails
through exposure to light at 28˚C for 1.5 h and were mechanically transformed into schistoso-
mula [66]. To obtain adult worms, 6–8 week old male BALB/c mice (Animal Resource Centre,
WA, Australia) were infected with 180 cercariae via tail penetration and adults were harvested
by vascular perfusion at 7–8 weeks post-infection [67]. Both adult worms and schistosomula
were cultured (10 adult pairs/ml and 2000 schistosomula/ml) at 37˚C and 5% CO2 in serum-
free modified Basch medium [68] supplemented with 4 × antibiotic/antimycotic (AA—200
units/ml penicillin, 200 μg/ml streptomycin and 0.5 μg/ml amphotericin B) (SFB) in 6 well
plates. Media containing ES products was initially collected after 3 h for schistosomula or 24 h
for adults, and replenished daily thereafter. ES products were stored at -80˚C. Media was
thawed when needed, concentrated through Amicon centrifugation filters (Sigma) with a 3
kDa molecular weight cutoff (MWCO), buffer exchanged into phosphate buffered saline, pH
7.4 (PBS) and aliquoted. Protein concentration of ES products was determined using the
Pierce BCA™ Protein Assay kit (Thermofisher). To collect cercarial ES products, freshly-shed
cercariae were incubated in H2O (4000/ml) at 25˚C for 3 h. H2O was filtered through What-
man filter paper (11 μm) to remove cercariae and associated debris, and ES products were con-
centrated, quantified and stored as described for adult and schistosomula ES products.
Parasite extract preparation
To make PBS-soluble extracts, worms were homogenized in PBS (50 μl/adult worm pair or
50 μl/1000 schistosomula) at 4˚C using a TissueLyser II (Qiagen), homogenates were incu-
bated overnight with mixing at 4˚C and the supernatants collected by centrifugation at 15,000
g for 1 h at 4˚C. Triton X-100-soluble extracts were made from the PBS-insoluble pellets by
resuspension in 1% Triton X-100, 40 mM Tris-HCl, pH 7.4, mixing overnight at 4˚C and the
supernatant collected by centrifugation at 15,000 g for 1 h at 4˚C. Tegument extraction was
achieved using a combination of freeze/thaw/vortex [69]. In brief, parasites were slowly thawed
on ice, washed in TBS (10 mM Tris/HCl, 0.84% NaCl, pH 7.4) and incubated for 5 min on ice
in 10 mM Tris/HCl, pH 7.4 followed by vortexing (5 × 1 s bursts). Subsequently, the tegumen-
tal extract was pelleted at 1000 g for 30 min and solubilized (3×) in 200 μl of 0.1% (w/v) SDS,
1% (v/v) Triton X-100 in 40 mM Tris, pH 7.4 with pelleting at 15,000 g between each wash.
Protein concentration was determined using the Pierce BCA Protein Assay kit, aliquoted and
stored at -80˚C until use.
Bioinformatics
Based on Pfam analysis (search = cholinesterase) of the S. mansoni genome (http://www.
geneDB.org/Homepage/Smansoni), three smche paralogs (smache1—smp_154600, smbche1—
smp_125350 and smache2—smp_136690) were identified. Homologous ChE sequences from
other species were identified using BLASTP. (http://blast.ncbi.nlm.nih.gov/Blast.cgi) and the
resulting sequences were used to generate a multiple sequence alignment using Clustal Omega
(https://www.ebi.ac.uk/Tools/msa/clustalo/). MEGA 7 was used to generate a neighbor-join-
ing tree with the Poisson correction distance method and a bootstrap test of 1,000 replicates
[70]. The tree was visualized with The Interactive Tree of Life (iTOF) online phylogeny tool
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(https://itol.embl.de/). Structure-homology 3D models of SmChEs were generated using the
I-TASSER server (http://zhanglab.ccmb.med.umich.edu/I-TASSER/). For structure visualiza-
tion and catalytic triad analyses, the Accelrys Discovery Studio (Accelerys Inc.) and UCSF Chi-
mera MatchMaker ver. 1.4 (University of California) software packages were utilized.
Real-time qPCR
Real-time qPCR was used to assess developmental expression of smche genes and to determine
smche transcript suppression resulting from RNAi experiments. RNA from miracidia, sporo-
cysts, cercariae, adult male worms, adult female worms, and eggs were obtained from BRI.
Schistosomula were cultured as described above, harvested (1,000 parasites) after either 3 h, 24
h, 3 or 5 days, washed three times in PBS and stored at -80˚C until use. Schistosomula from
RNAi experiments were similarly processed. Total RNA extraction was performed using the
Trizol (Thermofisher) reagent according to manufacturer’s instructions. After air-drying,
RNA pellets were re-suspended in 12 μl diethylpyrocarbonate (DEPC)-treated water. Concen-
tration and purity of RNA was determined using an ND2000 Nanodrop spectrophotometer
(Thermofisher). Synthesis of cDNA was carried out with 1 μg of total RNA using Superscript-
III-Reverse Transcriptase (Invitrogen) according to the manufacturer’s instructions. Finally,
cDNA was quantified, diluted to 50 ng/μl, aliquoted and stored at -20˚C.
Real-time qPCR primers for each smche (S1 Table) were designed using Primer3 (http://
frodo.wi.mit.edu/). The housekeeping gene smcox1 was selected as an internal control to nor-
malize relative smche gene expression [71]. Each qPCR (1 μl (50 ng) of cDNA, 5 μl of 2x SYBR
green master mix (Bioline), 1μl (5 pmol/μl) each of forward and reverse primers and 2 μl of
nuclease-free water) was run in a Rotor-Gene Q thermal cycler (Qiagen) using 40 cycles of
95˚C for 10 seconds, 50–55˚C for 15 seconds and 72˚C for 20 seconds. Stage-specific smche
gene expression levels were normalized against smcox1 (smp_900000) expression using the
comparative 2-ΔΔCT method [72]. All results represent the average of 5 independent experi-
ments with data presented as mean ± SEM.
Cloning, expression and purification of smche gene fragments in E. coli
Complete ORFs for smache1, smbche1 and smache2 were synthesized by Genewiz. Attempts to
express full-length sequences in E. coli were unsuccessful, so primer sets incorporating NdeI
(forward primer) and XhoI restriction enzyme sites (reverse primer) were designed (S1 Table)
to amplify partial, non-conserved regions of each smche, which might prove more amenable to
expression. Sequences (containing NdeI/ XhoI sites) for each SmChE were amplified from
each full-length template by PCR and cloned into the pET41a expression vector (Novagen)
such that the N-terminal GST tag was removed. Protein expression was induced for 24 h in E.
coli BL21(DE3) by addition of 1 mM Isopropyl beta-D-1-thiogalactopyranoside (IPTG) using
standard methods. Cultures were harvested by centrifugation (8,000 g for 20 min at 4˚C), re-
suspended in 50 ml lysis buffer (50 mM sodium phosphate, pH 8.0, 300 mM NaCl, 40 mM
imidazole) and stored at -80˚C. Cell pellets were lysed by three freeze-thaw cycles at -80˚C and
42˚C followed by sonication on ice (10 × 5 s pulses [70% amplitude] with 30 s rest periods
between each pulse) with a Qsonica Sonicator. Triton X-100 was added to each lysate at a final
concentration of 3% and incubated for 1 h at 4˚C with end-over-end mixing. Insoluble mate-
rial (containing SmChEs) was pelleted by centrifugation at 20,000 g for 20 min at 4˚C. The
supernatant was discarded, and inclusion bodies (IBs) were washed twice by resuspension in
30 ml of lysis buffer followed by centrifugation at 20,000 g for 20 min at 4˚C. IBs were then sol-
ubilized sequentially by resuspension in 25 ml lysis buffers containing either 2 M, 4 M or 8 M
urea, end-over-end mixing overnight at 4˚C and centrifugation at 20,000 g for 20 min at 4˚C.
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Finally, supernatant containing solubilized IBs was diluted 1:4 in lysis buffer containing 8M
urea and filtered through a 0.22 μm membrane (Millipore). Solubilized IBs were purified by
immobilized metal affinity chromatography (IMAC) by loading onto a prepacked 1 ml His-
Trap HP column (GE Healthcare) equilibrated with lysis buffer containing 8M urea at a flow
rate of 1 ml/min using an AKTA-pure-25 FPLC (GE Healthcare). After washing with 20 ml
lysis buffer containing 8M urea, bound His-tagged proteins were eluted using the same buffer
with a stepwise gradient of 50–250 mM imidazole (50 mM steps). Fractions containing
SmChEs (as determined by SDS-PAGE) were pooled and concentrated using Amicon Ultra-
15 centrifugal devices with a 3 kDa MWCO and quantified using the Pierce BCA Protein
Assay kit. The final concentration of each SmChE was adjusted to 1 mg/ml and proteins were
aliquoted and stored at -80˚C.
Generation of anti-rSmChE antisera and purification of IgG
Three groups of five male BALB/c mice (6-week-old) were intraperitoneally immunized with
either SmAChE1, SmBChE1 or SmAChE2 subunits (50 μg/mouse). Antigens were mixed with
an equal volume of Imject alum adjuvant (Thermofisher) and administered three times, two
weeks apart. Two weeks after the final immunization, mice were sacrificed and blood was col-
lected via cardiac puncture. Blood from all mice in each group was pooled and serum was sep-
arated by centrifugation after clotting and stored at −20˚C. Polyclonal antibodies were purified
from mouse sera using Protein A Sepharose-4B (Thermofisher) according to the manufactur-
er’s instructions. Serum from naïve mice was similarly processed.
Immunolocalization using anti-SmChE antisera
Adult worm sections. Freshly perfused adult S. mansoni and S. haematobium worms
were fixed in 4% paraformaldehyde, embedded in paraffin and sections (7 μm thick) were cut
in a cryostat. Following deparaffinization in xylene and rehydration in an ethanol series, anti-
gen retrieval was performed by boiling the slides in 10 mM sodium citrate, pH 6.0, for 40 min
followed by a solution of 10 mM Tris, 1 mM EDTA, 0.05% Tween, pH 9.0, for 20 min. All sec-
tions were then blocked with 10% heat-inactivated goat serum for 1 h RT. After washing 3
times with PBST, sections were incubated with anti-SmAChE1, anti-SmBChE1, anti-
SmAChE2, naïve sera (negative control), S. mansoni or S. haematobium infected mouse sera
(positive controls) (1:50 in PBST) overnight at 4˚C and then washed again (3 × 5 min each).
Finally, the sections were incubated with goat-anti-mouse IgG-alexafluor647 (Sigma) (1:200 in
PBST) for 1 h in the dark at RT. After a final washing step, slides were mounted with coverslips
in Entellan mounting medium (Millipore). Fluorescence and bright-field microscopy were
performed with an AxioImager M1 fluorescence microscope (Zeiss) using 10× and 20×
objectives.
Live schistosomula. In vitro cultured living cercariae and schistosomula (3 h, 24 h, 3 and
5 days old) were harvested, washed with PBS and then blocked with PBST/10% heat-inacti-
vated goat serum for 30 min at RT. Following three washes, the larvae were incubated with
anti-SmAChE1, anti-SmBChE1, anti-SmAChE2 or naïve serum (negative control) (1:100 in
PBST) overnight at 4˚C. Parasites were washed again before incubation with goat-anti-mouse
IgG-alexafluor647 (Sigma) (1: 200 in PBST) for 1 h in the dark at RT, followed by 3 washes.
Finally, schistosomes were fixed in 4% paraformaldehyde and transferred to a microscope
slide for fluorescence microscopy using an AxioImager M1 fluorescence microscope.
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Cloning and expression of full-length SmChEs in P. pastoris
Full-length sequences (minus the signal peptide) of SmAChE1, SmBChE1 and SmAChE2 were
EcoRI/XbaI cloned into the C-terminal 6-His-tagged pPICZαA expression vector (Invitrogen)
to facilitate secretory expression. Recombinant plasmids (20 μg) were linearized with Pmel
(SmAChE1 & SmBChE1) and SacI (SmAChE2), purified by ethanol precipitation and resus-
pended in 15 μl of H2O. Linearized vectors were electroporated according to the manufactur-
er’s instructions into P. pastoris X-33 cells (Thermofisher) in 2 mm cuvettes (2 ms, 2000V,
25 μF, 200O, square wave pulse), using a Gene Pulser Xcell (Bio-Rad), plated onto YPDS agar
plates containing 100 μg/ml zeocin and incubated for 3 days at 30˚C. Resultant colonies were
then picked and patched onto YPDS agar containing 2 mg/ml zeocin and plates incubated at
30˚C until colonies were visible. A high-expressing clone of each SmChE (determined from
pilot expression experiments) was used to inoculate 5 ml BMGY media supplemented with 50
ug/ml zeocin and grown overnight at 30˚C with rotation at 250 rpm. The entire culture was
then used to inoculate 250 ml of BMGY in a 2L baffled flask and incubation was continued for
24 h at 30˚C. Cells were pelleted at 5000 g for 20 min at RT, re-suspended in 1L of BMMY (to
induce protein expression) and split between 2 × 2L baffled flasks, which were incubated with
shaking (250 rpm) at 30˚C for 72 h. Methanol was added to a final concentration of 0.5% (2.5
ml/flask) every 24 h to maintain induction of protein expression. Culture medium containing
the secreted SmChE proteins was harvested by centrifugation (5000 g for 20 min at RT) and fil-
tered through a 0.22 μm membrane filter (Millipore). Recombinant proteins were purified by
IMAC using an AKTA-pure-25 FPLC (GE Healthcare). Briefly, culture medium was loaded
onto a 5 ml His-excel column, pre-equilibrated with binding buffer (50 mM PBS pH 7.4, 300
mM NaCl), washed with 20 column volumes of binding buffer and then eluted with binding
buffer containing a linear imidazole gradient (20 to 500 mM). The purity of fractions within
the main peak was analyzed by SDS-PAGE and fractions of appropriate purity were pooled,
concentrated and buffer exchanged into PBS using Amicon Ultra-15 centrifugal devices with a
3 kDa MWCO and quantified using the Pierce BCA Protein Assay kit. The final concentration
of each SmChE was adjusted to 1 mg/ml and proteins were aliquoted and stored at -80˚C.
SmChE enzyme assays
Activity of SmChEs (10 μg), extracts (20 μg) and ES samples (20 μg) was determined by the Ell-
man method [73]; modified for use with 96 well microplates. Samples (parasite extracts, ES
and SmChEs) were diluted in assay buffer (0.1M sodium phosphate, pH 7.4), and 2 mM acet-
ylthiocholine (AcSCh) or butyrylthiocholine (BcSCh) (Sigma) and 0.5 mM 5, 5’-dithio-bis
(2-nitrobenzoic acid) (DTNB) (Sigma) was added. The absorbance increase was monitored
every 5 min at 405 nm in a Polarstar Omega microplate reader (BMG Labtech). Specific activ-
ity was calculated using the initial velocity of the reaction and extinction coefficient of 13,260
M−1 cm−1 for TNB. To investigate sensitivity of parasite ES products to AChE inhibitors, 25 μg
of adult ES was pre-treated with 1 μM DDVP—active metabolite of the organophosphorous
AChE inhibitor metrifonate—for 20 min at RT before measuring activity. Kinetic parameters
of SmChEs were characterized by measuring enzyme activity at differing substrate concentra-
tions and plotting enzyme activity [V] vs. substrate concentration [S]. The Km ([S] at 1/2
Vmax) was calculated using the Michaelis Menton equation. Enzyme assays with inhibitors
were performed as above except that SmChEs in assay buffer were pre-treated with 1 μM
DDVP, in the case of SmAChE1 and SmAChE2, or 1 mM iso-OMPA–a membrane-imperme-
able specific BChE inhibitor—in the case of SmBChE1, for another 20 min at RT. Experiments
were performed in triplicate with data presented as the mean ± SEM.
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Purification of secreted SmChEs from adult S. mansoni ES products
Affinity chromatography using edrophonium chloride-sepharose was used to purify SmAChE
from S. mansoni based on the method of Hodgson and Chubb [74]. Briefly, 1 g of epoxy-acti-
vated sepharose 6B beads was washed with distilled H2O, the slurry centrifuged at 814 g for 5
min and the pellet gently resuspended in 50 mM sodium phosphate, pH 8.0, containing 200
mM edrophonium chloride (1:2 ratio of sepharose:edrophonium chloride). The pH of the
solution was adjusted to 10.0 and coupling of edrophonium with the sepharose was facilitated
by incubating the mixture overnight with shaking at 50˚C. The gel was then washed sequen-
tially with 10 volumes each of 100 mM sodium acetate, pH 4.5, 12 mM sodium borate, pH
10.0, and distilled H2O and finally resuspended in distilled H2O to generate a 1 ml gel slurry.
The gel slurry was packed into a chromatography column (10 cm long, 1 cm diameter) and
equilibrated by gravity flow at 4˚C with 10 column volumes (CV) of equilibration buffer (50
mM phosphate buffer, pH 8.0). Approximately 20 ml of ES from adult S. mansoni (concen-
trated through a 10 kDa MWCO centrifugal filter from a starting volume of 500 ml of media,
harvested each day for 7 days from 100 pairs of adult worms and buffer exchanged into equili-
bration buffer) was added to the column followed by washes with 20 CV of equilibration buffer
and 20 CV of equilibration buffer containing 500 mM NaCl. Bound SmChE was then eluted
with 10 CV of equilibration buffer containing 500 mM NaCl and 20 mM edrophonium chlo-
ride. The eluate was concentrated and buffer exchanged into PBS using a 10 kDa MWCO cen-
trifugal filter (edrophonium chloride is an AChE inhibitor and would interfere with
subsequent activity assays) and resolved by 10% SDS-PAGE to check purity and facilitate iden-
tification by mass spectrometry.
Mass spectrometric analysis of purified, secreted SmChE
Bands of interest were manually excised from the SDS polyacrylamide gel, washed with 50%
acetonitrile and dried under vacuum at 30˚C. Cysteine residues were reduced with 20 mM
DTT for 1 h at 65˚C followed by alkylation with 50 mM iodoacetamide for 40 min at 37˚C in
the dark. In-gel trypsin digestion was performed at 37˚C overnight with 0.8 ng of trypsin in
trypsin reaction buffer (40 mM ammonium bicarbonate, 9% acetonitrile). The supernatant
was removed to a fresh microfuge tube and stored at 4˚C, and the remaining peptides were fur-
ther extracted from the gel pieces by incubation with 0.1% trifluoracetic acid (TFA) at 37˚C for
45 min. The newly extracted supernatant was combined with the previously collected superna-
tant, then dried under vacuum. Prior to the matrix-assisted laser desorption/ionization-time-
of-flight mass spectrometry (MALDI-TOF MS) analysis, peptides were concentrated and
desalted using ZipTips (Millipore) following the manufacturer’s instructions. Tryptic peptides
were re-dissolved in 10 μl 5% formic acid and 6 μl was injected onto a 50 mm 300 μm C18 trap
column (Agilent Technologies) followed by an initial wash step with Buffer A (5% (v/v) ACN,
0.1% (v/v) formic acid) for 5 min at 30 μl/min. Peptides were eluted at a flow rate of 0.3 μl/min
onto an analytical nano HPLC column (15 cm × 75 μm 300SBC18, 3.5 μm, Agilent Technolo-
gies). The eluted peptides were then separated by a 55-min gradient of buffer B (90/10 acetoni-
trile/ 0.1% formic acid) 1–40% followed by a 5 min steeper gradient from 40–80%. The mass
spectrometer (ABSciex 5600 Triple Tof) was operated in data-dependent acquisition mode, in
which full scan TOF-MS data was acquired over the range of 350–1400 m/z, and over the
range of 80–1400 m/z for product-ion observed in the TOF-MS scan exceeding a threshold of
100 counts and a charge state of +2 to +5. Analyst 1.6.1 (ABSCIEX) software was used for data
acquisition and analysis.
For protein identification, a database was built using the S. mansoni genome v5.0 [http://
www.genedb.org/Homepage/Smansoni] with the common repository of adventitious proteins
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(cRAP, http://www.thegpm.org/crap/) appended to it. Mascot v.2.5.1 (Matrix Science) was
used for database search. Carbamidomethylation of Cys was set as a fixed modification and
oxidation of Met and deamidation of Asn and Gln were set as variable modifications. MS and
MS/MS tolerance were set at 10 ppm and 0.1 Da, respectively and only proteins with at least
two unique peptides (each composed of at least seven amino acid residues) identified were
considered reliably identified and used for analysis.
siRNA design and synthesis
Three short interfering RNA duplexes (siRNAs) targeting each of the three identified smche
paralogs were designed (S2 Table) and checked to avoid off-target silencing by BLAST search
using the S. mansoni genome. An irrelevant siRNA from firefly luciferase (luc) was selected as
a negative control [75]. All siRNAs were commercially synthesized (Integrated DNA Technol-
ogies) and oligonucleoitdes were suspended to a concentration of 1 μg/μl in DEPC-treated
water.
Electroporation of schistosomula with siRNA
Prior to electroporation, mechanically transformed schistosomula were cultured for 24 h
(2,000 schistosomula/ml), at 37˚C and 5% CO2 in SFB in 6 well plates. After 3 washes with
PBS, schistosomula were re-suspended in modified Basch medium (3,000 schistosomula/
100 μl) and 3,000 schistosomula were transferred into a Genepulser 4 mm electroporation
cuvette (Bio-Rad) for every siRNA treatment (four) and timepoint (four for each siRNA treat-
ment– 1, 3, 5 and 7 days). Schistosomula were electroporated with 10 μg of either luc, smache1,
smbche1 or smache2 siRNA (for individual knockdown experiments) or an equal combination
of all three smche siRNAs (30 μg total) or 30 μg luc siRNA (for combinatorial knockdown
experiments) using a Bio-Rad Gene Pulser Xcell (single 20 ms pulse– 125 V, 25 μF capacitance,
200O resistance, square wave electroporation) at RT, added to 24 well plates containing 1 ml
pre-warmed SFB and incubated (37˚C, 5% CO2) for 7 days. Schistosomula were harvested at
each timepoint and approximately 1,000 parasites were used for qPCR analysis (to assess tran-
script knockdown), 1,700 parasites were used for protein extract preparation (to examine phe-
notypic knockdown) and 300 parasites were used for Trypan Blue exclusion assays (to
determine parasite viability). All parasite material was generated and separately analyzed from
2 independent experiments.
Determination of viability in siRNA-treated schistosomula
Schistosomula (100 parasites/replicate) were harvested at each timepoint and viability was
determined by Trypan Blue exclusion staining [76]. Briefly, schistosomula were stained with
0.16% Trypan Blue in PBS with gentle shaking for 30 min at RT and then excess stain was
removed by multiple washes in PBS before fixing in 10% formalin. Parasites were counted
under 10× objective and live parasites (which had not taken up stain) were expressed as a per-
centage of total worms. Each assay was performed in triplicate.
Evaluation of protein expression in siRNA-treated schistosomula
Western blots were performed with day-7 parasite extracts (20 μg) following standard proce-
dures. The blots were probed with the anti-SmChE antibodies (1:1000 in PBST) generated
herein. A polyclonal anti-Sm-paramyosin antibody [75] was used as a loading control. Expres-
sion levels were quantified by comparative densitometry of bands resulting from luc- and
smche-treated parasite extracts (n = 1) using ImageJ software.
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Glucose uptake in schistosomula treated with siRNA
In a separate RNAi experiment, newly transformed schistosomula (5,000/treatment) were
incubated for 5 days in SFB. Parasites were then electroporated with siRNAs as described
above and finally transferred to serum-free DMEM (1 mg/ml glucose) supplemented with
4×AA. Media (50 μl) from each experiment was collected 48 h post-treatment and the amount
of glucose was quantified using a colorimetric glucose assay kit (Sigma) following the manu-
facturer’s instructions. Parasite viability at this timepoint was determined by Trypan Blue
exclusion and transcript levels of each smche, as well as the glucose transporters sgtp1
(smp_012440) and sgtp4 (smp_105410), were also measured. Glucose levels were normalized
according to the number of viable parasites and expressed relative to the luc group. Data is the
average of 2 biological and 3 technical replicates ± SEM.
Infection of mice with SmChE siRNA-treated schistosomula
One-day-old schistosomula (10,000) were electroporated as above in 500 μl of SFB with 50 μg
of either luc, smache1, smbche1 or smache2 siRNA or a combination of all three smche siRNAs
(150 μg total). Parasites were injected intramuscularly into both thighs (1,000 per thigh) of
male 6–8 week BALB/c mouse (5 mice per treatment group) using a 23-gauge needle. A con-
trol group of mice were similarly injected with non-electroporated schistosomula. Adult
worms were perfused 20 days later to assess the number of worms that had matured and
reached the mesenteries. Experiments were performed independently in duplicate. After trial
1, transcript levels of each smche from surviving worms were assessed using real-time qPCR.
Terminal bleeds were taken from all mice from each trial and serum (1:500 in PBST) was ana-
lysed by ELISA for the presence of anti-schistosome antibodies using ELISA plates coated with
cercarial transformation fluid [46].
Bio-scavenging of carboxylic esters by SmBChE1
To test the hypothesis that SmBChE1 may play a role in the bio-scavenging of AChE-inhibitory
molecules, we first sought to determine whether BChE activity of schistosome extracts or
recombinant SmBChE1 would be inhibited by DDVP. Schistosomula extracts (20 μg) or
SmBChE1 (10 μg) were diluted in assay buffer (final reaction volume was 200 μl), DDVP was
added to a final concentration of either 1, 2 or 5 μM (extract reactions) or 1, 5 or 10 μM
(SmBChE1 reactions) and the reactions incubated for 20 mins at RT. BcSCh (final concentra-
tion 2 mM) and DTNB (final concentration 0.5 mM) were then added and the absorbance was
monitored every 5 min at 405 nm in a Polarstar Omega microplate reader (BMG Labtech).
Next, we investigated whether inhibition of BChE activity would potentiate the AChE-
inhibitory and anti-schistosome effects of organophosphates (OP)s. Schistosomula extracts
(20 μg) were diluted in assay buffer (final reaction volume was 200 μl), then iso-OMPA was
added to a final concentration of either 1 or 2 mM and incubated for 20 min at RT. DDVP was
then added to a final concentration of 1 μM and the samples were further incubated for 20
min at RT. AcSCh (final concentration 2 mM) and DTNB (final concentration 0.5 mM) were
then added and the absorbance was monitored every 5 min at 405 nm. Extracts that were not
treated with iso-OMPA with or without DDVP treatment were used as controls. Experiments
were performed in triplicate with data presented as the mean ± SEM.
The same experiments were performed on live schistosomula using either an inhibitor- or
RNAi-based approach. For the inhibitor-based experiment, 24 h schistosomula (1,000/treat-
ment in 1 ml SFB) were pretreated with iso-OMPA at the non-lethal concentration of 100 μM
and, 1 h after iso-OMPA treatment, schistosomula were treated with 1 μM DDVP and cultured
for 5 h at 37˚C in 5% CO2. Parasites that were untreated, not treated with iso-OMPA but
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treated with DDVP and treated with iso-OMPA alone were used as controls. The parasites
treated with iso-OMPA alone were assayed for AChE activity as described above to investigate
any effect of iso-OMPA on AChE activity. For the RNAi-based experiment, 24 h schistosomula
(1,500/100 μl SFB) were electroporated with 10 μg of either smbche1 or luc siRNA as described
above, added to 24 well plates containing 1 ml pre-warmed SFB and incubated (37˚C, 5%
CO2) for 3 days before being treated with 1 μM DDVP and cultured for a further 5 h. Identical
experiments in the absence of DDVP were performed to control for the effects of RNAi alone.
For both inhibitor- and RNAi-based experiments, schistosomula viability was determined
using Trypan Blue staining. Data is presented as the mean ± SEM of 2 biological and 3 techni-
cal replicates.
In a reverse testing of the bio-scavenging hypothesis, we sought to determine whether addi-
tion of SmBChE could mitigate the effects of DDVP. Ten micrograms of SmBChE1 was pre-
incubated with 1 μM final concetration DDVP in AChE assay buffer (170 μl final volume) for
20 min at RT. Schistosomula extracts (20 μg), ACh (final concentration 2 mM) and DTNB
(final concentration 0.5 mM) were then added and the absorbance was monitored every 5 min
at 405 nm in a Polarstar Omega microplate reader. Reactions without SmBChE1 or without
DDVP were used as controls. Experiments were performed in triplicate with data presented as
the mean ± SEM. Again, the same experiments were performed on live schistosomula. After
the pre-treatment of different amounts of SmBChE1 (10, 5, and 2.5 μg) with 1 μM DDVP in
500 μl SFB, 24 h schistosomula (1,000/treatment in 500 μl SFB) were added, incubated at 37˚C
and 5% CO2 for 24 h and then parasite viability was measured by Trypan Blue staining. Experi-
ments where a similarly expressed and purified, but irrelevant, protein (SmTSP2 –
smp_181530) was used instead of SmBChE1, and schistosomula cultured in media alone, were
used as controls. Data is presented as the mean ± SEM of 2 biological and 3 technical
replicates.
Statistical analyses
Data were reported as the means ± SEM. Statistical differences were assessed using the stu-
dent’s t test. P values less than 0.05 were considered statistically significant.
Supporting information
S1 Fig. Regional amino acid sequence alignment of SmBChE1 and its human and other
helminth homologs. Accession numbers: Schistosoma mansoni (SmBChE1 –Smp_125350),
Schistosoma rodhaini (SROB_0000329201), Schistosoma haematobium (KGB33101), Schisto-
soma japonicum (Sjp_0015690), Clonorchis sinensis (csin111679), Echinostoma caproni
(ECPE_0000670801), Fasciola hepatica (PIS83327.1), Hymenolepis diminuta
(HDID_0000005301), Echinococcus granulosus (EGR_07475.1), Taenia solium
(TsM_000234300), Taenia saginata (TSAs00071g07627m00001), Trichuris muris
(TMUE_3000012587), Trichuris trichiura (TTRE_0000364501), Trichuris suis (M514_03850),
Nippostrongylus brasiliensis (NBR_0000102801), Caenorhabditis elegans (Y48B6A.8.1). Red
box = catalytic triad residue.
(TIF)
S2 Fig. Magnified view of 3D models showing the catalytic triads of SmChE paralogs. (A)
SmAChE1. (B) SmBChE1. (C) SmAChE2. The amino acid residues of the catalytic triad of
each paralog are magnified and their position number is given according to Torpedo AChE
numbering: SmAChE1 (Ser277, His542, Glu406), SmBChE1 (Ser244, Gln538, Glu406), and
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SmAChE2 (Ser239, His514, Glu375).
(TIF)
S3 Fig. Relationship between SmChEs and other invertebrate and vertebrate species. Evolu-
tionary history was inferred using the Neighbor-Joining method and the phylogenetic tree was
generated using a ClustalW alignment. The evolutionary distances were computed using the
Poisson correction method and are in the units of the number of amino acid substitutions per
site. All positions containing gaps and missing data were eliminated, making for a total of 236
positions in the final dataset. The three SmChEs are indicated by bold font inside a black box.
Accession numbers: Schistosoma mansoni (Sm_AChE1—Smp_154600, Sm_BChE1—
Smp_125350, Sm_AChE2—Smp_136690); Schistosoma bovis (Sb_AChE1—AAQ14323); Schis-
tosoma haematobium (Sh_AChE1—AAQ14322, Sh_AChE2—KGB33101, Sh_AChE3—
KGB33661); Schistosoma japonicum (Sj_AChE1—ANH56887, Sj_AChE2—Sjp0045440.1);
Clonorchis sinensis (Cs_AChE1—GAA52478, Cs_AChE2—GAA53463, Cs_AChE3—
GAA27255); Opisthorchis viverrini (Ov_AChE—XP009170845, Ov_AChE—XP009168237,
Ov_AChE—XP009170760); Echinococcus granulosus (Eg_AChE1—JN662938, Eg_AChE2—
EgG000732400); Hymenolepis microstoma (Hm_AChE1—LK053025); Taenia solium
(Ts_AChE1—TsM000234300, Ts_AChE—TsM001220100, Ts_AChE—TsM000001700);
Anopheles gambiae (Ag_AChE1—AGM16375); Aedes aegypti (Ae_AChE—AAB35001); Culex
tritaeniorhynchus (Ct_AChE—BAD06210); Caenorhabditis elegans (Ce_AChE1—NP510660,
Ce_AChE2—NP491141, Ce_AChE3—NP496963); Trichuris muris (Tm_AChE1—
TMUEs0033000600); Nippostrongylus brasiliensis (Nb_AChE1—AAK44221, Nb_AChE2—
AAC05785, Nb_AChE3—AAK44221); Homo sapiens (Hs_AChE—NP000656); Torpedo cali-
fornica (Tc_AChE—CAA27169); Danio rerio (Dr_AChE—NP571921); Mus musculus
(Mm_AChE—CAA39867); Rattus norvegicus (Rn_AChE—NP742006).
(TIF)
S4 Fig. Phylogenetic analysis of SmBChE1 and its human and other helminth homologs.
The phylogenetic tree was built using the maximum likelihood method with SmBChE1 and
the top 16 helminth ChE homologs identified from the BLASTp search, as well as human
BChE. Accession numbers: Schistosoma mansoni (SmBChE1 –Smp_125350), Schistosoma rod-
haini (SROB_0000329201), Schistosoma haematobium (KGB33101), Schistosoma japonicum
(Sjp_0015690), Clonorchis sinensis (csin111679), Echinostoma caproni (ECPE_0000670801),
Fasciola hepatica (PIS83327.1), Hymenolepis diminuta (HDID_0000005301), Echinococcus
granulosus (EGR_07475.1), Taenia solium (TsM_000234300), Taenia saginata
(TSAs00071g07627m00001), Trichuris muris (TMUE_3000012587), Trichuris trichiura
(TTRE_0000364501), Trichuris suis (M514_03850), Nippostrongylus brasiliensis
(NBR_0000102801), Caenorhabditis elegans (Y48B6A.8.1).
(TIF)
S5 Fig. Transcript levels of glucose transporters sgtp1 and sgtp4 and each smche in individ-
ual and cocktail smche siRNA-treated schistosomula. Transcript levels of each smche and
sgtp in parasites treated with smche siRNAs were determined 48 h after electroporation and are
shown relative to smche transcript expression in schistosomula treated with the luc control
siRNA (dashed line) and represent the mean ± SEM of triplicate qPCR assays from 2 biological
replicates of each treatment). Transcript expression in all parasites was normalized with the
housekeeping gene, smcox1. Differences in transcript levels (relative to the luc control) were
measured by the student’s t test. �P� 0.05, ��P� 0.01, ���P� 0.001.
(TIF)
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S6 Fig. Anti-schistosome IgG responses in mice injected with smache-silenced parasites
and smache transcript levels of parasites recovered from those mice. (A) For both trials, lev-
els of serum IgG antibodies to cercarial transformation fluid (CTF) were assessed in triplicate
by ELISA. Responses are shown relative to anti-CTF IgG responses of naïve mouse serum. (B)
For trial 1, transcript levels of each smche in parasites recovered from necropsied mice are
shown relative to smche transcript expression in schistosomula treated with the luc control
siRNA (dashed line) and represent the mean ± SEM of triplicate qPCR assays. Transcript
expression in all parasites was normalized with the housekeeping gene, smcox1.
(TIF)
S7 Fig. AcSCh conversion activity in schistosomula treated with iso-OMPA. (A) Schistoso-
mula (1000/treatment) were treated with iso-OMPA (50 and 100 μM) for 5 h and then assayed
for AcSCh conversion activity. Similarly cultured, untreated parasites were used as a control.
(B) Extracts were made from schistosomula from (A) and 20 μg each extract assayed for
AcSCh conversion activity. Data are the average ± SEM of duplicate biological and triplicate
technical experiments. Differences were measured by the student’s t test.
(TIF)
S8 Fig. SmBChE1 bio-scavenges DDVP and mitigates DDVP-induced effects. (A) Schisto-
somula extracts were treated with DDVP (1 μM), pretreated with iso-OMPA (1 and 2 mM)
and then DDVP, before assaying AsCSh conversion activity. Identical experiments were per-
formed in the absence of DDVP to control for AsCSh conversion activity by BChE. (B) Schis-
tosomula extracts were pre-incubated with fSmBChE1 (10 μg) then treated with DDVP
(1 μM), or treated with DDVP alone, before assaying AcSCh conversion activity. Identical
experiments were performed in the absence of DDVP to control for AsCSh conversion activity
by BChE. For all assays, data are the average of triplicate biological and technical
experiments ± SEM and differences were measured by the student’s t test. ��P� 0.01,
���P� 0.001.
(TIF)
S1 Table. Primers used in this study.
(DOCX)
S2 Table. Target sequences used to design siRNA duplexes.
(DOCX)
S3 Table. Identification by LC-MS/MS of SmChEs purified from adult S. mansoni ES prod-
ucts.
(DOCX)
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